Drug Approval | July 13, 2024
Lupin receives EIR from USFDA for its Dabhasa facility
The facility is a part of Lupin Manufacturing Solutions
The facility is a part of Lupin Manufacturing Solutions
The Unit has been issued GMP Certification from ANVISA-Brazil
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
Subscribe To Our Newsletter & Stay Updated
